Literature DB >> 3995214

Corticosteroid prescribing in rheumatoid arthritis--the fiction and the fact.

M A Byron, A G Mowat.   

Abstract

The results of a postal questionnaire to consultant rheumatologists (80% response rate) suggest that most comply with current teaching regarding the indications for systemic corticosteroids in articular rheumatoid arthritis (RA). They are prescribed as a last resort and most frequently in the elderly. However, a review of 100 consecutive RA out-patients revealed 24 patients currently taking corticosteroids at a mean prednisolone dosage of 5.6 mg daily. Only two had been prescribed these drugs for extra-articular problems. In 11 cases the treatment was not initiated by a rheumatologist. The discrepancies between the two surveys are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3995214     DOI: 10.1093/rheumatology/24.2.164

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  8 in total

1.  Corticosteroids in rheumatoid arthritis.

Authors:  E M Dennison; C Cooper
Journal:  BMJ       Date:  1998-03-14

2.  Corticosteroids in rheumatoid arthritis: is a trial of their 'disease modifying' potential feasible?

Authors:  M A Byron; J R Kirwan
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

3.  Inability of rheumatologists to describe their true policies for assessing rheumatoid arthritis.

Authors:  J R Kirwan; D M Chaput de Saintonge; C R Joyce; J Holmes; H L Currey
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

4.  Corticosteroid prescribing in rheumatoid arthritis and psoriatic arthritis.

Authors:  W Grassi; R De Angelis; C Cervini
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 5.  Managing early presentation of rheumatoid arthritis. Systematic overview.

Authors:  R Glazier
Journal:  Can Fam Physician       Date:  1996-05       Impact factor: 3.275

Review 6.  Effects of glucocorticoids on radiological progression in rheumatoid arthritis.

Authors:  J R Kirwan; J W J Bijlsma; M Boers; B J Shea
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

7.  Alpha-methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy.

Authors:  Jungyeon Hwang; Kathleen Rodgers; James C Oliver; Thomas Schluep
Journal:  Int J Nanomedicine       Date:  2008

8.  Inhibition of the production of mediators of inflammation by corticosteroids is a glucocorticoid receptor-mediated process.

Authors:  G S Madretsma; A P Dijk; C J Tak; J H Wilson; F J Zijlstra
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.